Lv10
28046 积分 2020-10-16 加入
A multicenter, randomized, double-blinded, placebo-controlled, phase Ⅲ study evaluating the efficacy and safety of Xeligekimab (GR1501) in patients with moderate-to-severe plaque psoriasis
10天前
已完结
A multicenter, randomized, double-blinded, placebo-controlled, phase Ⅲ study evaluating the efficacy and safety of Xeligekimab (GR1501) in patients with moderate-to-severe plaque psoriasis
1个月前
已完结
The effect of IL17 and IL23 inhibitors on hematological parameters and C-reactive protein in psoriasis patients
1个月前
已完结
结核分枝杆菌γ-干扰素释放试验及临床应用专家意见（2021年版）
1个月前
已完结
Efficacy and safety of single-agent belantamab mafodotin versus pomalidomide plus low-dose dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-3): a phase 3, open-label, randomised study
1个月前
已完结
Evolving Landscape of Antibody Drug Conjugates in Lymphoma
1个月前
已完结
Backfilling cohorts in phase I dose-escalation studies
2个月前
已完结
A multicenter, randomized, double-blinded, placebo-controlled, dose-ranging study evaluating the efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis
3个月前
已完结
Pharmacokinetics, Safety, and Efficacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Plaque Psoriasis: A Phase 1, Single- and Multiple-Dose Study
4个月前
已完结
Does previous use of tumour necrosis inhibitors change the therapeutic effect of interleukin ( IL )‐17 or IL ‐12/23 inhibitors on psoriasis and psoriatic arthritis? Results of a systematic review
4个月前
已完结
Innate Immune System Response to Burn Damage—Focus on Cytokine Alteration
2天前
已采纳
Constructivist Grounded Theory: characteristics and operational aspects for nursing research
2天前
已采纳
皖公网安备34019202002308
